Literature DB >> 26351337

Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.

F Christopher Holsinger1, Robert L Ferris2.   

Abstract

Transoral endoscopic head and neck surgery is a new approach for the treatment of oropharyngeal tumors. Using either a robotic system and/or laser, surgeons gain access through the mouth via minimally invasive technique and thus have improved visualization of the tumors of the oropharynx, without disfiguring incisions. This transoral route of access minimizes long-term speech and swallowing dysfunction. Surgeons view this approach as a considerable technologic advance, analogous to the evolution in radiation therapy from conventional two- and three-dimensional conformal techniques to intensity-modulated techniques. Although the use of radiation with or without chemotherapy to treat oropharyngeal cancer (OPC) is supported by evidence from prospective clinical trials, there are no prospective data supporting the use of this new surgical approach for OPC. Here, we review the fundamentals of transoral endoscopic head and neck surgery, with robotics and laser technology, and discuss ongoing clinical trials for patients with OPC.
© 2015 by American Society of Clinical Oncology.

Entities:  

Mesh:

Year:  2015        PMID: 26351337      PMCID: PMC4586168          DOI: 10.1200/JCO.2015.62.3157

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  39 in total

1.  SIGNIFICANCE OF RETROPHARYNGEAL NODES IN CANCER OF THE HEAD AND NECK.

Authors:  A J BALLANTYNE
Journal:  Am J Surg       Date:  1964-10       Impact factor: 2.565

2.  To TORS or Not to TORS: but is that the question? Comment on "transoral robotic surgery for advanced oropharyngeal carcinoma".

Authors:  Adam S Garden; Merrill S Kies; Randal S Weber
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-11

3.  The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory.

Authors:  A Y Chen; R Frankowski; J Bishop-Leone; T Hebert; S Leyk; J Lewin; H Goepfert
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2001-07

4.  Transoral robotic surgery and human papillomavirus status: Oncologic results.

Authors:  Marc A Cohen; Gregory S Weinstein; Bert W O'Malley; Michael Feldman; Harry Quon
Journal:  Head Neck       Date:  2010-12-06       Impact factor: 3.147

5.  Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract.

Authors:  W Steiner
Journal:  Adv Otorhinolaryngol       Date:  1988

6.  Laser surgery in the larynx. Early clinical experience with continuous CO 2 laser.

Authors:  M S Strong; G J Jako
Journal:  Ann Otol Rhinol Laryngol       Date:  1972-12       Impact factor: 1.547

7.  Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives.

Authors:  Janet A Wilson; Paul N Carding; Joanne M Patterson
Journal:  Otolaryngol Head Neck Surg       Date:  2011-07-11       Impact factor: 3.497

8.  Transoral robotic-assisted surgery for head and neck squamous cell carcinoma: one- and 2-year survival analysis.

Authors:  Hilliary N White; Eric J Moore; Eben L Rosenthal; William R Carroll; Kerry D Olsen; Reneé A Desmond; J Scott Magnuson
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-12

9.  Human papillomavirus and rising oropharyngeal cancer incidence in the United States.

Authors:  Anil K Chaturvedi; Eric A Engels; Ruth M Pfeiffer; Brenda Y Hernandez; Weihong Xiao; Esther Kim; Bo Jiang; Marc T Goodman; Maria Sibug-Saber; Wendy Cozen; Lihua Liu; Charles F Lynch; Nicolas Wentzensen; Richard C Jordan; Sean Altekruse; William F Anderson; Philip S Rosenberg; Maura L Gillison
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

10.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Authors:  Christopher M Nutting; James P Morden; Kevin J Harrington; Teresa Guerrero Urbano; Shreerang A Bhide; Catharine Clark; Elizabeth A Miles; Aisha B Miah; Kate Newbold; MaryAnne Tanay; Fawzi Adab; Sarah J Jefferies; Christopher Scrase; Beng K Yap; Roger P A'Hern; Mark A Sydenham; Marie Emson; Emma Hall
Journal:  Lancet Oncol       Date:  2011-01-12       Impact factor: 41.316

View more
  39 in total

1.  Assessment of Surgical Learning Curves in Transoral Robotic Surgery for Squamous Cell Carcinoma of the Oropharynx.

Authors:  William G Albergotti; William E Gooding; Mark W Kubik; Mathew Geltzeiler; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-06-01       Impact factor: 6.223

2.  Positive Margins by Oropharyngeal Subsite in Transoral Robotic Surgery for T1/T2 Squamous Cell Carcinoma.

Authors:  Michael J Persky; William G Albergotti; Tanya J Rath; Mark W Kubik; Shira Abberbock; Mathew Geltzeiler; Seungwon Kim; Umamaheswar Duvvuri; Robert L Ferris
Journal:  Otolaryngol Head Neck Surg       Date:  2017-11-28       Impact factor: 3.497

Review 3.  Robotics in otorhinolaryngology - head and neck surgery.

Authors:  George Garas; Neil Tolley
Journal:  Ann R Coll Surg Engl       Date:  2018-09       Impact factor: 1.891

4.  Early assessment of feasibility and technical specificities of transoral robotic surgery using the da Vinci Xi.

Authors:  Philippe Gorphe; Jean Von Tan; Sophie El Bedoui; Dana M Hartl; Anne Auperin; Quentin Qassemyar; Antoine Moya-Plana; François Janot; Morbize Julieron; Stephane Temam
Journal:  J Robot Surg       Date:  2017-01-07

5.  Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.

Authors:  Eleni M Rettig; Munfarid Zaidi; Farhoud Faraji; David W Eisele; Margueritta El Asmar; Nicholas Fung; Gypsyamber D'Souza; Carole Fakhry
Journal:  Oral Oncol       Date:  2018-06-27       Impact factor: 5.337

6.  [Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides].

Authors:  Alexander Fabian; David Krug
Journal:  Strahlenther Onkol       Date:  2020-02       Impact factor: 3.621

7.  Reconstruction of TORS oropharyngectomy defects with the nasoseptal flap via transpalatal tunnel.

Authors:  Meghan T Turner; Mathew Geltzeiler; W Greer Albergotti; Umamaheswar Duvvuri; Robert L Ferris; Seungwon Kim; Eric W Wang
Journal:  J Robot Surg       Date:  2019-06-10

Review 8.  Current Role of Surgery in the Management of Oropharyngeal Cancer.

Authors:  Meghan T Turner; J Kenneth Byrd; Robert L Ferris
Journal:  J Oncol Pract       Date:  2016-11       Impact factor: 3.840

9.  What should we expect from robotic surgery for second primary oropharyngeal cancer?

Authors:  Tuan-Jen Fang; Li-Ang Lee; Bing-Shan Huang; Chien-Yu Lin; Cheng-Lung Hsu; Joseph Tung-Chieh Chang; Tzu-Chen Yen; Chun-Ta Liao; Hui-Chen Chiang
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-05-09       Impact factor: 2.503

Review 10.  Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.

Authors:  Ari J Rosenberg; Everett E Vokes
Journal:  Oncologist       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.